Exact Mass: 294.1596
Exact Mass Matches: 294.1596
Found 500 metabolites which its exact mass value is equals to given mass value 294.1596,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Vinburnine
Eburnamonine is an alkaloid. Vinburnine is a natural product found in Kopsia pauciflora, Aspidosperma quebracho-blanco, and other organisms with data available. C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids C1907 - Drug, Natural Product relative retention time with respect to 9-anthracene Carboxylic Acid is 0.645 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.638 Vincamone is a vinca alkaloid and a metabolite of vincamine, is a vasodilator. Vincamone is a vinca alkaloid and a metabolite of vincamine, is a vasodilator.
Cinchonidine
Cinchonine is found in fruits. Cinchonine is an alkaloid from the leaves of Olea europaea Cinchonine is an alkaloidwith molecular formula C19H22N2O used in asymmetric synthesis in organic chemistry. It is a stereoisomer and pseudo-enantiomer of cinchonidine D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents [Raw Data] CB216_Cinchonine_pos_10eV_CB000075.txt [Raw Data] CB216_Cinchonine_pos_30eV_CB000075.txt [Raw Data] CB216_Cinchonine_pos_40eV_CB000075.txt [Raw Data] CB216_Cinchonine_pos_50eV_CB000075.txt [Raw Data] CB216_Cinchonine_pos_20eV_CB000075.txt Alkaloid from the leaves of Olea europaea Cinchonidine (α-Quinidine) is a cinchona alkaloid found in Cinchona officinalis and Gongronema latifolium. A building block used in asymmetric synthesis in organic chemistry. Weak inhibitor of serotonin transporter (SERT) with Kis of 330, 4.2, 36, 196, 15 μM for dSERT, hSERT, hSERT I172M, hSERT S438T, hSERT Y95F, respectively. Antimalarial activities[1]. Cinchonidine (α-Quinidine) is a cinchona alkaloid found in Cinchona officinalis and Gongronema latifolium. A building block used in asymmetric synthesis in organic chemistry. Weak inhibitor of serotonin transporter (SERT) with Kis of 330, 4.2, 36, 196, 15 μM for dSERT, hSERT, hSERT I172M, hSERT S438T, hSERT Y95F, respectively. Antimalarial activities[1]. Cinchonine is a natural compound present in Cinchona bark. Cinchonine activates endoplasmic reticulum stress-induced apoptosis in human liver cancer cells[1]. Cinchonine is a natural compound present in Cinchona bark. Cinchonine activates endoplasmic reticulum stress-induced apoptosis in human liver cancer cells[1].
5,10-dihydro-9-dimethylallylphenazine-1-carboxylic acid
A member of the class of phenazines that is 5,10-dihydrophenazine substituted at positions 1 and 9 by carboxy and dimethylallyl groups respectively.
2-[(2E)-3,7-Dimethyl-2,6-octadienyl]-1,4-naphthoquinone
Cinchonidine
Cinchonidine is 8-epi-Cinchonan in which a hydrogen at position 9 is substituted by hydroxy (R configuration). A diasteroisomer of cinchonine, it occurs in the bark of most varieties of Cinchona shrubs, and is frequently used for directing chirality in asymmetric synthesis. It has a role as a metabolite. It is a cinchona alkaloid and an (8xi)-cinchonan-9-ol. It derives from a hydride of an (8S)-cinchonan. Cinchonidine is a natural product found in Cinchona calisaya, Cinchona officinalis, and other organisms with data available. 8-epi-Cinchonan in which a hydrogen at position 9 is substituted by hydroxy (R configuration). A diasteroisomer of cinchonine, it occurs in the bark of most varieties of Cinchona shrubs, and is frequently used for directing chirality in asymmetric synthesis. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids Annotation level-1 [Raw Data] CBA34_Cinchonidine_pos_50eV_1-2_01_1626.txt [Raw Data] CBA34_Cinchonidine_pos_40eV_1-2_01_1625.txt [Raw Data] CBA34_Cinchonidine_pos_20eV_1-2_01_1623.txt [Raw Data] CBA34_Cinchonidine_pos_30eV_1-2_01_1624.txt [Raw Data] CBA34_Cinchonidine_pos_10eV_1-2_01_1617.txt Cinchonidine (α-Quinidine) is a cinchona alkaloid found in Cinchona officinalis and Gongronema latifolium. A building block used in asymmetric synthesis in organic chemistry. Weak inhibitor of serotonin transporter (SERT) with Kis of 330, 4.2, 36, 196, 15 μM for dSERT, hSERT, hSERT I172M, hSERT S438T, hSERT Y95F, respectively. Antimalarial activities[1]. Cinchonidine (α-Quinidine) is a cinchona alkaloid found in Cinchona officinalis and Gongronema latifolium. A building block used in asymmetric synthesis in organic chemistry. Weak inhibitor of serotonin transporter (SERT) with Kis of 330, 4.2, 36, 196, 15 μM for dSERT, hSERT, hSERT I172M, hSERT S438T, hSERT Y95F, respectively. Antimalarial activities[1]. Cinchonine is a natural compound present in Cinchona bark. Cinchonine activates endoplasmic reticulum stress-induced apoptosis in human liver cancer cells[1]. Cinchonine is a natural compound present in Cinchona bark. Cinchonine activates endoplasmic reticulum stress-induced apoptosis in human liver cancer cells[1].
Alosetron
Alosetron is a 5-HT3 antagonist used only for the management of severe diarrhoea-predominant irritable bowel syndrome (IBS) in women. Alosetron has an antagonist action on the 5-HT3 receptors and thus may modulate serotonin-sensitive gastrointestinal (GI) processes. Alosetron was voluntarily withdrawn from the US market in November 2000 by the manufacturer due to numerous reports of severe adverse effects including ischemic colitis, severely obstructed or ruptured bowel, and death. In June 2002, the FDA approved a supplemental new drug application allowing the remarketing of the drug under restricted conditions of use. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AE - Serotonin receptor antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D005765 - Gastrointestinal Agents
Sinapoylputrescine
Sinapoylputrescine is found in fruits. Sinapoylputrescine is an alkaloid from Ananas comosus (pineapple). Alkaloid from Ananas comosus (pineapple). Sinapoylputrescine is found in fruits.
(R)-Rhazinilam
Alkaloidal artifact from Aspidosperma quebracho-blanco (quebracho).
Longistylin A
Longistylin A is found in pulses. Longistylin A is isolated from leaves of Cajanus cajan (pigeon pea). Isolated from leaves of Cajanus cajan (pigeon pea). Longistylin A is found in pulses.
Tocopheronic acid
Human metabolite of a-Tocopherol
Tyrosyl-Leucine
Tyrosyl-Leucine is a dipeptide composed of tyrosine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Ginsenoyne B
Ginsenoyne B is found in tea. Ginsenoyne B is present in ginseng root. Present in ginseng root. Ginsenoyne B is found in tea.
(E,E)-1,6-bis(4-methoxyphenyl)-1,5-hexadiene
Neolignan from essential oil of Ocimum americanum (wild basil). (E,E)-1,6-bis(4-methoxyphenyl)-1,5-hexadiene is found in herbs and spices. (E,E)-1,6-bis(4-methoxyphenyl)-1,5-hexadiene is found in herbs and spices. Neolignan from essential oil of Ocimum americanum (wild basil
Leucyl-Tyrosine
Leucyl-Tyrosine is a dipeptide composed of leucine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Tyrosyl-Isoleucine
Tyrosyl-Isoleucine is a dipeptide composed of tyrosine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Isoleucyl-Tyrosine
Isoleucyl-Tyrosine is a dipeptide composed of isoleucine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Nigellidine
Nigellidine is found in herbs and spices. Nigellidine is an alkaloid from seeds of Nigella sativa (black cumin). Alkaloid from seeds of Nigella sativa (black cumin). Nigellidine is found in herbs and spices.
Mono-(2-ethyl-5-hydroxyhexyl) phthalate
Mono-(2-ethyl-5-hydroxyhexyl) phthalate, also known as 40321-99-1 or phthalic acid mono(2-ethyl-5-hydroxyhexyl) ester, is classified as a member of the benzoic acid esters. Benzoic acid esters are ester derivatives of benzoic acid. 40321-99-1 is considered to be practically insoluble (in water) and acidic. (ChemoSummarizer) Mono-(2-ethyl-5-hydroxyhexyl) phthalate is a metabolite of mono(2-ethylhexyl) phthalate (MEHP) and a secondary metabolite of di(2-ethylhexyl) phthalate (DEHP) [Exposome-Explorer]. Di(2-ethylhexyl) phthalate (DEHP) is added to polyvinyl chloride (PVC) plastics used widely in medical devices and toys to impart flexibility and durability (Pubmed: 16332407).
4-[(E)-5,6-Dihydro-2,3'-bipyridin-3(4H)-ylidenemethyl]-3-methoxyphenol
Retinoid 9CUAB30
Benzoic acid, 4-(4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-1-ynyl)-, (E)-
tiaden
C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites
3-Methoxy-4-(3-methyl-2-buten-1-yl)-5-[(1E)-2-phenylethenyl]phenol; Longistyline C
4-chloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide
2-chloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide
3-chloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide
2H-1,5-Benzodiazepin-2-one, 1,3,4,5-tetrahydro-5-acetyl-1-(phenylmethyl)-
troxipide
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent
11-(phenylcarbonyl)-7,11-diazatricyclo[7.3.1.0<2,7>]trideca-2,4-dien-6-one
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.738 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.734
botryosphaerin B|rel-(3aS,5aR,6S,9aS,9bR)-1,2,3a,5a,6,7,8,9,9a,9b-decahydro-10a-hydroxy-3a-(hydroxymethyl)-6,9a-dimethyl-2-oxonaphtho[2,1]furan-6-carboxylic acid
4-hydroxy-5-propionyl-1,3-di-O-methyl-2-O-isopentenylpyrogallol
(3aS*,6R*,6aR*,9R*,9aR*,9bR*)-3a,4,5,6,6a,9,9a,9b-octahydro-6,9-dihydroxy-6a-methoxy-6,9-dimethyl-3-methyleneazuleno<4,5-b>furan-2(3H)-one
(3Z,9Z,12E)-7-acetoxy-6-chloropentadeca-3,9,12-trien-1-yne
12-Ethenyl-10-ethyl-7,8,9,10-tetrahydro-11H-6,10-methano-5,6-diazacycloocta[b]naphthalene-3-ol
8beta-hydroxy-8alpha-methoxy-3-oxo-eremophil-1,7(11)-dien-12-oic acid
(3R),(6R)-6-hydroxy-de-O-methyllasiodiplodin|(3R,6S)-6-hydroxy-de-O-methyllasiodiplodin|F7855-2
(6R,7R)-3-cis,9-cis,12-cis,6-acetoxy,7-chloro-pentadeca-3,9,12-trien-1-yne|6(R),7(R)-3-cis-9-cis-12-cis-6-acetoxy-7-chloropentadeca-3,9,12-trien-1-yne
Me ester-(??)-Phaseic acid|Me ester-楼?脥-楼?脦-Phaseic acid
1-(2,2-Dimethyl-5,6,7-trimethoxy-alpha-chromene-8-yl)ethanol
2,2,6-Trimethyl-4-(acetoxymethyl)-5-(2-chloroethyl)indan
(3-vinyl-1,2,3,4,6,7,12,12b-octahydro-2,6-methano-indolo[2,3-a]quinolizin-13-yl)-methanol|(9-vinyl-5,6,8,9,10,11,12a,13-octahydro-6,10-methano-indolo[3,2-b]quinolizin-12-yl)-methanol|19,20-dihydro-sarpag-18-en-17-ol|Neosarpagin
10-methoxy-16-methylene-3,7-seco-6-nor-condyfola-2(7),14(19)-diene|10-methoxy-3,7-seco-6-nor-cura-2(7),16,19-triene|10-Methoxyapparicin|4-ethylidene-10-methoxy-6-methylene-1,3,4,5,6,7-hexahydro-2,5-ethano-azocino[4,3-b]indole
trans-2-<3-(4-methoxyphenyl)-1-propen-2-yl>anethol|trans-2-[3-(4-methoxyphenyl)-1-propen-2-yl]anethol
2,2-Dimethyl-7-methoxy-5-(2-phenylethyl)-2H-1-benzopyran
(1S,2R,5R,6S,7S,8S,10R)-6-hydroxy-2-methoxy-4-oxopseudoguai-11(13)-en-12,8-olide
A pseudoguaianolide with anti-inflammatory activity isolated from the aerial parts of Inula hupehensis.
(3S,12R)-3-hydroxy-1,7-diazatricyclo[10.4.0.(13,7)]heptadecane-11,16,17-trione|(7S,15aR)-decahydro-7-hydroxy-6H-7,11-methano-4H-pyrido[1,2-a][1,7]diazacyclododecine-4,15,16(12H)-trione|alopecurin A
(7R,8R)-threo-Delta8-7-acetoxy-4-methoxy-8-O-4-neolignan|miliusamollin
5-Ethyl-7,12-etheno-6,5-(iminoethano)-2,3,4,5-tetrahydro-1H-1-benzoazonine-2,13-dione
2alpha-methoxy-8alpha-hydroxy-6-oxogermacra-1(10),7(11)-dien-8,12-olide
(E)-3-(3,5-dimethoxy-4-((2R)-methylbutyryloxy)phenyl)prop-2-enol|dichrocephol A
(7R,8S)-3-methoxy-4-hydroxy-4?,7-epoxy-8,3?-neolignan-7?[E]-ene
Me ester -(1(10)E,4alpha,6alpha)-15-Hydroxy-1(10),11(13)-germacradien-12,6-olid-14-oic acid|Methyl 15-hydroxy-4betaH-germacra-1(10)E,11(13)-trien-6alpha,12-olide-14-oic acid
4beta-acetoxy-6alpha-hydroxy-1alpha.10betaH-pseudoguaia-11(13)-en-12.8alpha-olide
3-(4-Methoxyphenyl)-2-[2-methoxy-5-(2-propenyl)phenyl]propene
1beta,10beta-Epoxy-6beta-hydroxy-8beta-methoxyeremophil-7(11)-en-12,8alpha-olide
3,8-dihydroxy-13-methoxy-4(15),10(14)-guaiadien-12,6-olide
6alpha-acetoxy-4beta-hydroxy-1alpha,10betaH-pseudoguaia-11(13)-en-12.8alpha-olide
1,2-dehydrodesacetyl-retuline|1,2-Dehydrodesacetylretuline
(14alpha,15alpha)-14,15-epoxyaspidofractinine|(1aR,8bR,11aR,12aS)-4H,12H-1b,3b-ethano-1a,2,3,9,10,12a-hexahydro-11aH-oxireno[6,7]indolizino[8,1-cd]carbazole
6-acetyl-2alpha,5-dihydroxy-2-(2-hydroxypropyl)- 3alpha,8-dimethylchroman
arglanilic acid methyl ester|artanoate|methyl(4R,5S,6S,7S,10R)-1-oxo-4,6-dihydroxy-eudesma-2,11(13)-dien-12-oate
Nigellidine
Longistyline A
Longistyline A is a natural product found in Cajanus cajan with data available.
Cinchonine
Cinchonan in which a hydrogen at position 9 is substituted by hydroxy (S configuration). It occurs in the bark of most varieties of Cinchona shrubs, and is frequently used for directing chirality in asymmetric synthesis. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents Origin: Plant; Formula(Parent): C19H22N2O; Bottle Name:Cinchonine; PRIME Parent Name:Cinchonine; PRIME in-house No.:V0325; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids Annotation level-1 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.610 Acquisition and generation of the data is financially supported by the Max-Planck-Society IPB_RECORD: 2401; CONFIDENCE confident structure Cinchonine is a natural compound present in Cinchona bark. Cinchonine activates endoplasmic reticulum stress-induced apoptosis in human liver cancer cells[1]. Cinchonine is a natural compound present in Cinchona bark. Cinchonine activates endoplasmic reticulum stress-induced apoptosis in human liver cancer cells[1].
(E)-7-(4-methoxy-5-methyl-6-oxopyran-2-yl)-5-methyloct-6-enoic acid
(E)-4-hydroxy-4-[4-oxo-2-[(E)-6-oxohept-1-enyl]cyclopentyl]but-2-enoic acid
3-methoxy-4-(3-methylbut-2-enyl)-5-[(E)-2-phenylethenyl]phenol
C19H22N2O_(3alpha,16alpha)-14,15-Dihydroeburnamenin-14-one
alosetron
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AE - Serotonin receptor antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D005765 - Gastrointestinal Agents
eburnamonine
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids
(E)-7-(4-methoxy-5-methyl-6-oxopyran-2-yl)-5-methyloct-6-enoic acid [IIN-based: Match]
(E)-7-(4-methoxy-5-methyl-6-oxopyran-2-yl)-5-methyloct-6-enoic acid [IIN-based on: CCMSLIB00000846906]
Ile-tyr
A dipeptide formed from L-isoleucine and L-tyrosine residues.
Leu-tyr
A dipeptide formed from L-leucine and L-tyrosine residues.
Tyr-ile
A dipeptide formed from L-tyrosine and L-isoleucine residues.
Tyr-leu
A dipeptide formed from L-tyrosine and L-leucine residues.
Tocopheronic acid
Rhazinilam
(E,E)-1,6-bis(4-methoxyphenyl)-1,5-hexadiene
4-Amino-N-(tert-butoxycarbonyl)-L-phenylalanine Methyl Ester
Puromycin aminonucleoside
D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Puromycin aminonucleoside (NSC 3056) is the aminonucleoside portion of the antibiotic puromycin, and used in nephrosis animal models[1]. Puromycin aminonucleoside induces apoptosis[2]. Puromycin aminonucleoside is a reversible inhibitor of dipeptidyl peptidase II and cytosol alanyl aminopeptidase[3]. Puromycin aminonucleoside induces secretion of cell migrasome[4].
6-Methyl-2-(4-methylphenyl) imidazo [1,2-a]-pyridine-3-acetate methyl ester
(S)-tert-butyl3-amino-2-(((benzyloxy)carbonyl)amino)propanoate
1-[2-AMINO-1-(2,5-DIMETHOXY-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
1-[2-AMINO-1-(3,4-DIMETHOXY-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
(4-(Diisopropylcarbamoyl)-2-ethoxypyridin-3-yl)boronic acid
tert-butyl 4-(1-cyano-2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate
Methyl 3-fluoro-4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
tert-butyl 4-(4-fluoroanilino)piperidine-1-carboxylate
4-ETHYLPHENYLAMINO-1,2-DIMETHYL-6-METHYLAMINOPYRIMIDINIUM CHLORIDE
6-phenyl-4-(3-phenylaziridin-2-yl)-3-oxa-5-azabicyclo[3.1.0]hexan-2-ol
4,4,5,5-TETRAMETHYL-2-(3,4,5-TRIMETHOXYPHENYL)-1,3,2-DIOXABOROLANE
Methanone, 1,9-diazaspiro[5.5]undec-1-ylphenyl-, hydrochloride (1:1)
Methanone, 1,9-diazaspiro[5.5]undec-9-ylphenyl-, hydrochloride (1:1)
Noxiptiline
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents
tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate
3-methyl-3-[3-(methylamino)propyl]-1-phenylindol-2-one
TERT-BUTYL 4-(3-FLUOROBENZYL)PIPERAZINE-1-CARBOXYLATE
3-(3-FLUORO-BENZYLAMINO)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
3-(4-FLUORO-BENZYLAMINO)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
Methyl 2,3-O-Isopropylidene-5-O-benzyl-β-D-ribofuranoside
dihydrogen phosphate,1-methyl-3-octyl-1,2-dihydroimidazol-1-ium
4-(2-methyl-6-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)morpholine
4-[(4-FLUOROPHENYL)METHYL]-1,1-PIPERAZINECARBOXYLIC ACID, 1,1-DIMETHYLETHYL ESTER
2-dibenzofuran-2-yl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
17-ethenyl-2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-triene
4-Ethoxycarbonyl-2-fluorobenzeneboronic acid pinacol ester
Methyl 2-(4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Methyl 4-fluoro-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
2-(3-benzylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
4-[benzotriazol-1-yl(phenyl)methyl]morpholine,4-[benzotriazol-2-yl(phenyl)methyl]morpholine
(S)-5,5,6,6,7,7,8,8-octahydro-[1,1-binaphthalene]-2,2-diol
2-(Dibenzo[b,d]furan-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Retinoid 9CUAB30
C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent
Benzoic acid, 4-(4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-1-ynyl)-, (E)-
Methyl 3-(4-aminophenyl)-2-[(tert-butoxycarbonyl)amino]propanoate
1-[5-(4-Methoxyphenyl)-3-phenyl-3,4-dihydropyrazol-2-yl]ethanone
6-Amino-4-(2-methylpropyl)-3-phenyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
1-(2-(2-Methyl-5-pyridyl)ethyl)-5-methoxy-2,3-dimethylindole
Norgestrienone
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
2H-Indol-2-one, 1,3-dihydro-3-methyl-3-(3-(methylamino)propyl)-1-phenyl-, (S)-
TIADENOL
C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites
Puromycin aminonucleoside
D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents
2-Quinuclidinemethanol, alpha-4-quinolyl-5-vinyl-
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
[(1S,12S,13R,14S,15E)-15-ethylidene-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraen-13-yl]methanol
(S)-[(2S,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-quinolin-4-ylmethanol
4-[(E)-5,6-Dihydro-2,3-bipyridin-3(4H)-ylidenemethyl]-3-methoxyphenol
[3-Carboxy-2-(3,4,5-trihydroxypentanoyloxy)propyl]-trimethylazanium
(R)-[(2R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(4-quinolinyl)methanol
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
1-[(E)-[4-(Dimethylamino)phenyl]methylideneamino]-3-(3-methoxypropyl)thiourea
10-Deoxysarpagine
An indole alkaloid that is sarpagan bearing a hydroxy group at position 17.
6-methoxy-3-[(3-methylanilino)methyl]-1H-quinolin-2-one
N-(2,4-dimethoxyphenyl)-3-(4-morpholinyl)propanamide
N-(1-acetyl-2,3-dihydroindol-5-yl)-4-methylbenzamide
4-[2-(4-hydroxyphenyl)-4-propyl-1H-pyrazol-5-ylidene]-1-cyclohexa-2,5-dienone
2,4-dimethyl-N-[4-(1-pyrrolidinyl)phenyl]benzamide
(3,4-Dimethylphenyl)-(4-phenyl-1-piperazinyl)methanone
(1-Methyl-2-imidazolyl)-(4-phenylmethoxyphenyl)methanol
4-methyl-N-(3-methyl-1-phenylbutylidene)benzohydrazide
N-(3-methoxyphenyl)-2-(1-methyl-3-indolyl)acetamide
(E)-7-(4-methoxy-5-methyl-6-oxopyran-2-yl)-5-methyloct-6-enoic acid
(2S,3R,4S)-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile
(2S,3S,4S)-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
N-[(3R,5Z,12S)-2,11-dioxo-10-oxa-1-azabicyclo[10.3.0]pentadec-5-en-3-yl]acetamide
(2S,3S,4S)-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile
(2R,3S,4R)-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4R)-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile
(2S,3R,4R)-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile
(2S,3R,4S)-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4R)-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4R)-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4S)-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile
(2S,3R,4R)-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3S,4S)-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
N-butyl-N(2)-[(R)-2-hydroxy-2-phenylacetyl]-L-serinamide
N-[(E)-2-Bicyclo[2.2.1]heptanylideneamino]-3-hydroxynaphthalene-2-carboxamide
(E)-4-hydroxy-4-[4-oxo-2-[(E)-6-oxohept-1-enyl]cyclopentyl]but-2-enoic acid
MONO(2-ETHYL-5-HYDROXYHEXYL) PHTHALATE
A phthalic acid monoester obtained by formal condensation of one of the carboxy groups of phthalic acid with the primary hydroxy group of 2-ethylhexane-1,5-diol
(R)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(4-quinolinyl)methanol
VQW-765
VQW-765 (AQW-051) is a selective and orally active alpha-7 nicotinic acetylcholine receptor (α7-nAChR) agonist with a pKD value of 7.56 to recombinantly expressed human α7-nAChR. VQW-765 shows anxiolytic-like effect in vivo. VQW-765 can be used for the research of anxiety disorder and acute performance anxiety[1].
